FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

96215002: Sumatriptan succinate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
159287012 Sumatriptan succinate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
840532018 Sumatriptan succinate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
18261000188115 sumatriptan succinate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
843231000172111 succinate de sumatriptan fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sumatriptan succinate Is a Serotonin uptake inhibitor false Inferred relationship Some
Sumatriptan succinate Is a Serotonin 5-HT1 receptor agonist true Inferred relationship Some
Sumatriptan succinate Is a Sumatriptan (substance) false Inferred relationship Some
Sumatriptan succinate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Serotonin 5-hydroxytryptamine-1 receptor agonist (disposition) true Inferred relationship Some
Sumatriptan succinate Is a Sulfonamide (substance) true Inferred relationship Some
Sumatriptan succinate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Sumatriptan (substance) true Inferred relationship Some
Sumatriptan succinate Is a vasoconstricteur false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Sumatriptan succinate 6mg injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Sumatriptan succinate 12mg/mL injection solution 0.5mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Sumatriptan succinate 25mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Sumatriptan 50mg rapid release tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Sumatriptan 100mg rapid relase tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Sumatriptan 4mg injection solution prefilled cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Sumatriptan 6mg injection solution prefilled cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
sumatriptan 12 mg/mL, seringue préremplie de 0,5 mL d'une solution injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some 1
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some 1
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some 1
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sumatriptan succinate Inferred relationship Some 1
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sumatriptan succinate Inferred relationship Some 2
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sumatriptan succinate Inferred relationship Some 2
Product containing precisely sumatriptan succinate 25 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sumatriptan succinate Inferred relationship Some 1
Product containing precisely sumatriptan (as sumatriptan succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sumatriptan succinate Inferred relationship Some 1
Sumatriptan (as sumatriptan succinate) 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sumatriptan succinate Inferred relationship Some 1
Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sumatriptan succinate Inferred relationship Some 2
Sumatriptan succinate 12 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sumatriptan succinate Inferred relationship Some 1
Sumatriptan succinate 12 mg/mL solution for injection This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Sumatriptan succinate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start